Obstetrics and gynecology · Flowchart
Preeclampsia
FreeCause to treatmentHY high-yield
Preeclampsia from abnormal placentation to prevention: sFlt-1 and endothelial damage, the definition and severe features, eclampsia and HELLP, delivery timing, blood pressure control, magnesium sulfate and low-dose aspirin.
Updated
Whole chart as designed

Read this flowchart as text
The same content as the chart above, step by step. Points marked high-yield are the ones most often tested.
1. Cause
- Abnormal placentation: Spiral arteries are not remodelled → poorly perfused placenta (high-yield)
- Risk factors: First pregnancy, previous preeclampsia, chronic hypertension, diabetes, kidney disease, SLE or antiphospholipid syndrome, twins, obesity, IVF
2. Pathogenesis
- Placenta releases antiangiogenic factors: High sFlt-1, low PlGF → widespread endothelial damage
- Vasoconstriction: Hypertension
- Leaky, damaged endothelium: Proteinuria, edema, organ injury
3. Definition
- New BP 140/90 or more after 20 weeks: Plus proteinuria or signs of organ damage (high-yield)
- Severe features: BP 160/110 or more, platelets under 100,000, raised liver enzymes or RUQ pain, creatinine over 1.1, pulmonary edema, headache or visual changes (high-yield)
4. Diagnosis
- Tests: Urine protein/creatinine 0.3 or more (or 300 mg/24 h); platelets, creatinine, liver enzymes
- The spectrum: Gestational hypertension (no protein or organ damage) → preeclampsia → eclampsia or HELLP
5. Complications
- Eclampsia: Seizures
- HELLP: Hemolysis, Elevated Liver enzymes, Low Platelets (high-yield)
- Others: Abruption, stroke, pulmonary edema, kidney injury; fetal growth restriction
6. Treatment
- Delivery is the cure: No severe features: deliver at 37 weeks. Severe features: at 34 weeks, sooner if unstable (high-yield)
- Severe BP: IV labetalol or hydralazine, or oral nifedipine
- Magnesium sulfate: Prevents and treats seizures; watch reflexes and breathing (high-yield)
- Steroids: Betamethasone before 34 weeks for the baby's lungs
7. Prevention
- Low-dose aspirin: From 12–16 weeks in women at high risk